![Ron Squarer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ron Squarer
Président chez
ADC THERAPEUTICS SA
Fortune : 7 M $ au 31/05/2026
Profil
Ron Squarer is currently Chairman at ADC Therapeutics SA since 2020.
Mr. Squarer is Director at Deciphera Pharmaceuticals LLC since 2019.
Mr. Squarer is Independent Director at Travere Therapeutics, Inc. since 2017.
Mr. Squarer is Independent Director at Nuvalent, Inc. starting in 2025.
Formerly, Mr. Squarer was Chief Executive Officer & Director at Array BioPharma, Inc. from 2012 to 2019.
Mr. Squarer was Chairman at Deciphera Pharmaceuticals, Inc. from 2023 to 2024.
Mr. Squarer was Principal at Smithkline Beecham Plc.
Mr. Squarer was Chief Commercial Officer & Senior Vice President at Hospira, Inc. from 2010 to 2011.
Mr. Squarer was Senior Vice President-Business Development at Mayne Pharma Ltd. from 2006 to 2007.
Mr. Squarer completed undergraduate studies at the University of California, Berkeley.
Mr. Squarer earned an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 1,26% | 03/06/2026 | 1 607 627 ( 1,26% ) | 5 M $ | 31/05/2026 |
| 19/05/2026 | 39 375 ( 0,04% ) | 2 M $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Ron Squarer
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/04/2017 |
| ADC THERAPEUTICS SA | Président | 01/03/2020 |
| NUVALENT, INC. | Directeur/Membre du Conseil | 09/12/2025 |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Directeur/Membre du Conseil | 01/12/2019 |
Anciens postes connus de Ron Squarer
| Sociétés | Poste | Fin |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Président | 11/06/2024 |
| ARRAY TECHNOLOGIES, INC. | Directeur Général | 01/08/2019 |
| HOSPIRA, INC. | Corporate Officer/Principal | 01/02/2012 |
Mayne Pharma Ltd.
 Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2007 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formation de Ron Squarer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
